Orchestra BioMed and Medtronic have worked together on the new therapy, which is designed to work automatically without patients needing to take any additional steps. Orchestra BioMed and Medtronic have worked together on the new therapy, which is designed to work automatically without patients needing to take any additional steps. | | |
|
Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons. Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons. | | |
|
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD. Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD. | | |
|
The Millipede 088 was designed to treat large vessel occlusion stroke patients by “ingesting” the blood clot as opposed to dragging it through the patient’s blood vessels. The Millipede 088 was designed to treat large vessel occlusion stroke patients by “ingesting” the blood clot as opposed to dragging it through the patient’s blood vessels. | | |
|
|
India-based Meril Life Sciences has been manufacturing its Myval transcatheter heart valves for years, but the technology has not yet gained FDA approval. This latest head-to-head comparison included data from more than 1,000 TAVR patients. India-based Meril Life Sciences has been manufacturing its Myval transcatheter heart valves for years, but the technology has not yet gained FDA approval. This latest head-to-head comparison included data from more than 1,000 TAVR patients. | | |
|
The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available. The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available. | | |
|
Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients. Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients. | | |
|
Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes. Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes. | | |
|
|
Researchers detailed their experience performing the very first TAVR procedures with the Venus-PowerX TAVR valve from Venus MedTech. The valve includes a wire-controlled mechanism that makes it possible to recapture after full deployment. Researchers detailed their experience performing the very first TAVR procedures with the Venus-PowerX TAVR valve from Venus MedTech. The valve includes a wire-controlled mechanism that makes it possible to recapture after full deployment. | | |
|
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more. COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more. | | |
|
Sending helpful alerts through email and the electronic health record can make a significant impact on patient care, according to new data presented at ACC.25 and published in Circulation. Sending helpful alerts through email and the electronic health record can make a significant impact on patient care, according to new data presented at ACC.25 and published in Circulation. | | |
|
|
By automating repetitive tasks and ensuring consistent “QC,” well-deployed AI not only unburdens healthcare professionals but also sets new standards for efficiency and reliability in medical practice. By automating repetitive tasks and ensuring consistent “QC,” well-deployed AI not only unburdens healthcare professionals but also sets new standards for efficiency and reliability in medical practice. | | |
|
Certain PowerPICC Intravascular Catheters manufactured by BD and its subsidiary Bard Access Systems are to be removed from patient care settings immediately. Certain PowerPICC Intravascular Catheters manufactured by BD and its subsidiary Bard Access Systems are to be removed from patient care settings immediately. | | |
|